Shiseido’s Vital Perfection Intensive SculptDefine Serum makes a particularly arresting promise: facial contours that appear visibly redefined by 68% after four weeks. On the UK product page, the footnote attributes that figure to self-scoring by 104 women. A separate one-week claim about improvement in sagging, firmness and brightness refers to a clinical test on 33 women.
Those two footnotes are the place to begin. The larger number describes participants’ assessments, while the other result comes from a differently labelled study with a smaller group. Combining them into a single claim that a clinical trial measured a 68% change would lose an important distinction in the brand’s own wording.
This is a current autumn skincare launch, rather than something first announced this week. Shiseido issued its US launch announcement on 1 September 2026; its Japanese announcement, published in May, gave 1 September as that market’s on-sale date. We have not established the first UK sale date. The serum is now listed on Shiseido’s UK website at £118 for 40ml and £192 for 80ml.
The formula story is built around Shiseido’s D-AminoLift Complex, which the brand identifies with D-aspartic acid, niacinamide and SafflowerRED. Its US announcement also discusses watercress extract and the brightening ingredient 4MSK. These are the company’s explanations of the formula’s intended activity, not an independent demonstration of how much any one ingredient contributes to the finished product’s results.
What the percentages leave open
A self-assessment can tell a brand whether people perceive a difference. It does not, by itself, tell a shopper exactly what that difference would look like on their own face. Nor should a percentage attached to a scoring system be imagined as the same percentage of loose skin disappearing. To interpret the size of a change properly, a reader would need to understand the scale used, the starting scores and what was being compared.
The public UK listing gives the group sizes and time points, but does not provide a complete study report explaining those details. That limits how far we can analyse the result from the page alone. It is not evidence that the serum does nothing, and it would be equally premature to treat the headline number as a predictable personal outcome. TBQ has not tested it.
There is a more straightforward calculation available on the price. The 40ml bottle works out at £2.95 per ml, while the 80ml bottle is £2.40 per ml. Buying the larger size costs £74 more upfront; it is £44 less than buying two 40ml bottles at the listed prices. A lower unit price is useful if you already know you want the product, but it gives no extra information about whether the formula will suit you.
The practical reading of this launch is therefore more modest than its biggest number. Shiseido is reporting encouraging results from its own testing, with different methods behind different claims. Keeping those methods attached to the promises makes the product easier to judge, without requiring either an immediate purchase or an automatic dismissal.
Reported from Shiseido’s official UK listings and launch announcements. This is a claims examination, not a product review or a promise of treatment results. Prices and online availability checked 25 October 2026; both can change.